The Sickle Cell Blood Drive with the American Red Cross runs 9 a.m. to 2 p.m. Saturday at Apostolic Church of Jesus Christ, 2420 SE Bellview Ave.

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

Sickle cell disease can take a toll on couples, but it's entirely possible to maintain a healthy relationship, says columnist.

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Discover Agios Pharmaceuticals' Q4 2024 earnings highlights, growth plans for Pyrukynd in thalassemia & sickle cell, and insights on safety, clinical ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...

Researchers at Johns Hopkins Medicine have discovered that a drug originally developed for Alzheimer’s disease, schizophrenia ...

High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...

Get Digital Liver initiative News on Telangana Today, Digital Liver initiative latest news, Digital Liver initiative news, | Telangana Today ...